Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02754544 · ClinicalTrials.gov registry record · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
A NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02754544: Recruiting NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT02754544 is a NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 75 participants, below the 86-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02754544, a NA study of Metastatic Malignant Neoplasm in the Brain and Brain Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping may help doctors to better identify which areas of the brain are active during specific limb movement and speech during surgery in patients with brain tumors.
Primary Outcome
Will be assessed by cortical electrical activity based on individual hand muscle function. ECoG will be compared to direct electrical stimulation (DES), navigated transcranial magnetic stimulation (nTMS), and functional magnetic resonance imaging (fMRI). The data obtained using ECoG will be correlated with the fMRI and TMS data acquired preoperatively and intraoperative DES. The categorical variables would be preoperative Karnofsky performance status and functional status, tumor location, fMRI,
Conditions Studied
Interventions
- PROCEDURE Direct Electrocortical Stimulation
- OTHER Electrocorticography
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-07-22 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT02754544 shows while recruiting
NCT02754544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 86-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (13% lower).
The record links to 3 conditions, with Metastatic Malignant Neoplasm in the Brain appearing as the primary indexed condition, and to 2 interventions - of which Direct Electrocortical Stimulation is the first listed.
NCT02754544 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02754544 about?
NCT02754544 is a clinical study titled "Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors". This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping...
What is the current status of trial NCT02754544?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2016-07-22. Estimated completion is 2028-01-01.
What conditions does trial NCT02754544 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Brain, Brain Neoplasm, Recurrent Brain Neoplasm.
What interventions are being tested in trial NCT02754544?
The interventions under investigation include: Direct Electrocortical Stimulation (PROCEDURE), Electrocorticography (OTHER).
Who is sponsoring clinical trial NCT02754544?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02754544 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02754544's enrollment target sits among peer trials
75 18th of 43 higher than 26 of 43 other Metastatic Malignant Neoplasm in the Brain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Malignant Neoplasm in the Brain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
RECRUITING · NA
-
nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
ACTIVE NOT RECRUITING · NA
-
Mind-Body Intervention in Glioma Couples
ACTIVE NOT RECRUITING · NA
-
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT03128034 · 75 participants · Phase 1
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI